title: HIV fusion and its inhibition.
authors.affiliation: Department of Surgery, Duke University Medical Center, Durham, NC, USA. celia.labranche@duke.edu
authors.forename: C C
authors.initials: CC
authors.lastname: LaBranche
authors.forename: G
authors.initials: G
authors.lastname: Galasso
authors.forename: J P
authors.initials: JP
authors.lastname: Moore
authors.forename: D P
authors.initials: DP
authors.lastname: Bolognesi
authors.forename: M S
authors.initials: MS
authors.lastname: Hirsch
authors.forename: S M
authors.initials: SM
authors.lastname: Hammer
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001596:Benzylamines; D016860:CD4 Immunoadhesins / Q000494:pharmacology / Q000627:therapeutic use; D000080027:Cyclams; D000077560:Enfuvirtide; D006678:HIV / Q000187:drug effects* / Q000502:physiology; D015700:HIV Envelope Protein gp41 / Q000494:pharmacology / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D006571:Heterocyclic Compounds / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008561:Membrane Fusion / Q000187:drug effects*; D010446:Peptide Fragments / Q000494:pharmacology / Q000627:therapeutic use; D015728:Receptors, HIV / Q000187:drug effects / Q000378:metabolism*
chemical_list: D019380:Anti-HIV Agents; D001596:Benzylamines; D016860:CD4 Immunoadhesins; C096753:CD4-IgG(2); D000080027:Cyclams; D015700:HIV Envelope Protein gp41; D006571:Heterocyclic Compounds; D010446:Peptide Fragments; D015728:Receptors, HIV; D000077560:Enfuvirtide; C088327:plerixafor